Results 181 to 190 of about 25,057,042 (262)

Domain specific multimodal large language model for automated endoscopy reporting with multicenter prospective validation. [PDF]

NPJ Digit Med
Jiang R, Chen B, Dong Z, Zeng X, You H, Li Y, Deng Y, Mu G, Wang J, Huang L, Li J, Cheng D, Zhou W, Yu H.   +13 more
europepmc   +1 more source

Double-Balloon Enteroscopy Enhanced With a Magnetic Balloon Anchoring System: A Triple Balloon Novel Approach for Diagnosis and Treatment of Small Bowel Lesions. [PDF]

ACG Case Rep J
Minerba P, Rossi G, Rosa C, Parzanese MI, Alvisi C.   +4 more
europepmc   +1 more source

Outcomes and adverse effects of teduglutide treatment with periodic withdrawal in pediatric short bowel patients

Journal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 1, Page 37-45, July 2026.
Abstract Objectives We evaluated the efficacy and safety of teduglutide in a real‐world cohort in which national reimbursement policies required treatment interruptions. The primary outcomes were reduction in parenteral support (PS) and treatment‐related adverse effects, and the secondary outcome was the impact of the mandated withdrawal periods ...
Riikka Gunnar, Annika Mutanen, Mikko P. Pakarinen, Laura Merras‐Salmio   +3 more
wiley   +1 more source

Endoscopic ultrasound-guided dual-route recanalization of isolated hepatic ducts following complete hilar disconnection. [PDF]

Endoscopy
Ni J, Su G, Xu K, Gong X, Li B.
europepmc   +1 more source

Updated European Reference Network for rare Inherited and Congenital Digestive and Gastrointestinal Anomalies guidelines for the management of rectosigmoid Hirschsprung's disease 2025

Journal of Pediatric Gastroenterology and Nutrition, Volume 83, Issue 1, Page 185-207, July 2026.
Abstract Objectives To revise the 2018 European Reference Network for rare Inherited and Congenital Digestive and Gastrointestinal Anomalies (ERNICA) clinical guideline for the management of rectosigmoid Hirschsprung's disease (HSCR) based on new evidence and evolving clinical priorities, ensuring continued relevance, trustworthiness, and consistency ...
Daniel Rossi, Willemijn Irvine, Anna Löf Granström, Annika Mutanen, Roel Bakx, Kristin Bjørnland, Duccio Cavalieri, Piotr Czauderna, Anne Dariel, Mark Ellebæk, Francesco Fascetti Leon, Fabio Fusaro, Dirk‐Jan Gloudemans, Marietta Jank, Peter Kolja Kvist, Martin Lacher, Annette Lemli, Lucas Matthyssens, Louise Montalva, Pedro Palazon, Alessio Pini Prato, Lucie Pos, Roxana Rassouli‐Kirchmeier, Konrad Reinshagen, Nagoud Schukfeh, Rony Sfeir, Olivia Spivack, Pernilla Stenström, Lovisa Telborn, Eelke Toxopeus, Alejandra Vilanova, Miriam Wilms, Rene Wijnen, Cornelius E. J. Sloots, Mikko Pakarinen, Tomas Wester   +35 more
wiley   +1 more source

Correction: Management of multicausal iatrogenic bile duct injuries with biliary fistula: Twenty-year experience in a tertiary center. [PDF]

Endosc Int Open
Garbay V, Ratone JP, Zemmour C, Hoibian S, Dahel Y, Palen A, Garnier J, Ewald J, Turrini O, Giovannini M, Caillol F.   +10 more
europepmc   +1 more source

Gastroscopic Evaluation of Gastric Mucosa in Horses Treated With Flunixin Meglumine or High‐Dose Firocoxib: A Descriptive Pilot Study

Veterinary Medicine and Science, Volume 12, Issue 4, July 2026.
In this descriptive pilot study, short‐term (5‐day) high‐dose firocoxib (1.0 mg/kg) was not associated with detectable gastric mucosal injury in horses. Due to non‐randomised design and small sample size (n = 5/group), no causal conclusions can be drawn. Findings are hypothesis‐generating and require confirmation in adequately powered trials.
Renato Abrantes de Oliveira, Alexandre da Silva Correa, Francisco Décio de Oliveira Monteiro, Pedro Paulo Maia Teixeira   +3 more
wiley   +1 more source

A case report: an unusual case of multiple jejunal foreign bodies. [PDF]

BMC Gastroenterol
Jiang Y, Chen H, Gao Z, Mei D, Xie Y.
europepmc   +1 more source

Correlation of Bile Acid Dynamics to Bulevirtide Response and Disease Severity in Patients With Hepatitis D

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 2, Page 196-207, July 2026.
Bulevirtide increases bile acid levels in most patients; however, changes in bile acids do not predict virological response or adverse events, nor do they reflect treatment adherence. After discontinuation of bulevirtide, bile acid levels rapidly decline.
Marlene Hintersteininger, Michael Schwarz, Philipp Schwabl, Lukas Hartl, Lorenz Balcar, Benedikt Silvester Hofer, Georg Kramer, Christian Sebesta, Paul Thöne, Patrik Attalla, Michael Gschwantler, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Mathias Jachs   +14 more
wiley   +1 more source

Novel therapeutic ultrathin endoscope facilitates endoscopic intermuscular dissection for gastrointestinal stromal tumor adjacent to the anus. [PDF]

Endoscopy
Li T, Huang S, Liao S, Guo Q, Zhong E, Zhang Y, Wang H.   +6 more
europepmc   +1 more source